DISSOCIATION OF NUCLEAR AND CYTOPLASMIC CELL-CYCLE PROGRESSION BY DRUGS EMPLOYED IN CELL SYNCHRONIZATION

被引:78
作者
URBANI, L [1 ]
SHERWOOD, SW [1 ]
SCHIMKE, RT [1 ]
机构
[1] STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA
关键词
D O I
10.1006/excr.1995.1216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have studied the effect of the cell synchronization agents compactin, ciclopirox olamine, mimosine, aphidicolin, ALLN, and colcemid on several parameters of cell cycle progression in mitotically synchronized HeLa S3 cells. Using cell size and cyclin A and B levels as markers of cytoplasmic progression and DNA content as a measure of nuclear cell cycle position, we have examined coordination of cytoplasmic and nuclear events during induction synchrony. Each synchronizing agent was unique in its effect on the coordination of the cytoplasmic and nuclear cycle. Mimosine, aphidicolin, ALLN, and colcemid disrupted cell cycle integration while compactin and ciclopirox olamine did not, Continued net cell growth during cell cycle arrest was the most dramatic in aphidicolin-treated cells, which averaged a 60% increase in size. Mimosine, ALLN, and colcemid produced an increase in cell size of approximately 25%, and ciclopyrox olamine and compactin exerted a negligible effect. Cyclin A and B were found at mitotic (high) or G1 (low) levels, or in combination of high and low concentrations not correlated with DNA content in drug-treated cells. For example, treatment with mimosine, which arrests cells in G1 with 2C DNA, resulted in cyclin A accumulating to mitotic levels, whereas cyclin B remained at a low concentration, the first time this phenomenon has been observed. These results demonstrate that populations of synchronized cells obtained by different drug treatments are blocked at biochemically distinct cell cycle points not apparent by cytometric measurement of DNA content. Our results provide conclusive evidence that induced synchrony methods differ with respect to their impact on cell cycle organization and from the pattern seen with nonperturbing cell selection methods. (C) 1995 Academic Press, Inc.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 50 条
  • [41] PERTURBATION OF CELL-CYCLE PROGRESSION WITH MELPHALAN INVITRO
    BARLOGIE, B
    DREWINKO, B
    CANCER TREATMENT REPORTS, 1976, 60 (12): : 1981 - 1981
  • [42] EFFECTS OF ANTINEOPLASTIC AGENTS ON THE CELL-CYCLE PROGRESSION
    CHARCOSSET, JY
    BIOLOGY OF THE CELL, 1986, 58 (02) : 135 - 138
  • [43] Nucleostemin: a multiplex regulator of cell-cycle progression
    Ma, Hanhui
    Pederson, Thoru
    TRENDS IN CELL BIOLOGY, 2008, 18 (12) : 575 - 579
  • [44] Tools for Assessing Cell-Cycle Progression in Plants
    Echevarria, Clara
    Gutierrez, Crisanto
    Desvoyes, Benedicte
    PLANT AND CELL PHYSIOLOGY, 2021, 62 (08) : 1231 - 1238
  • [45] The vacuole/lysosome is required for cell-cycle progression
    Jin, Yui
    Weisman, Lois S.
    ELIFE, 2015, 4
  • [46] DECILIATION INTERFERES WITH CELL-CYCLE PROGRESSION IN TETRAHYMENA
    SEYFERT, HM
    NEUFANG, M
    WILLECKE, R
    EXPERIMENTAL CELL RESEARCH, 1985, 158 (01) : 159 - 169
  • [47] A novel function of muskelin in cell-cycle progression
    Valiyaveettil, M
    Hussein, R
    Chakravarti, R
    Cannon, J
    Adams, JC
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 21A - 21A
  • [48] Polyamine dependence of normal cell-cycle progression
    Oredsson, SM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 366 - 370
  • [49] MODULATING EFFECTS OF DRUGS ON CELL-CYCLE KINETICS
    RONOT, X
    ADOLPHE, M
    BIOLOGY OF THE CELL, 1986, 58 (02) : 139 - 146
  • [50] CELL-CYCLE SYNCHRONIZATION IN ASTROCYTES AND ASTROCYTOMA-CELLS
    LANGAN, TJ
    SCHROT, RJ
    KELLY, K
    JOURNAL OF NEUROCHEMISTRY, 1994, 62 : S72 - S72